Loading...
Loading...
ACST| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 4,245.0K |
| Gross Profit | -4,245.0K |
| Operating Expense | 4,245.0K |
| Operating I/L | -4,245.0K |
| Other Income/Expense | 82.0K |
| Interest Income | 64.0K |
| Pretax | -4,163.0K |
| Income Tax Expense | -274.0K |
| Net Income/Loss | -3,889.0K |
Acasti Pharma Inc. is a biopharmaceutical company specializing in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company's primary focus is on the clinical development of CaPre, a potential treatment for cardiovascular conditions. Acasti Pharma Inc. generates revenue through strategic partnerships and the eventual commercialization of its pharmaceutical products.
